NEW YORK, August 5, 2026, 07:15 EDT — U.S. premarket.
- UiPath Inc. finished Tuesday’s session at $14.10, rising 8.05%. Shares were indicated at $14.22 ahead of Wednesday’s market open.
- The closing price was $0.83 higher than the $13.27 mean analyst target. The highest target of $15 implied a 6.4% potential gain.
- Preliminary net-new ARR for Q2 is projected at $30.5 million, indicating a 37.8% decrease compared with Q1.
UiPath’s surge sent a stronger signal than just its headline jump. The stock outperformed other software names and broke through the average Wall Street target.
This reduces the scope for sentiment-driven moves. Investors now look for solid gains in recurring revenue or a further upward revision to guidance.
The S&P 500 climbed 1.79% on Tuesday, while the Nasdaq advanced 2.59%. Shares of Palantir Technologies Inc. NASDAQ:PLTR jumped 29.5% after the company lifted its revenue guidance for the year.
| Security | Latest move from previous close | UiPath advantage |
|---|---|---|
| UiPath | +8.05% | — |
| iShares Expanded Tech-Software Sector ETF (BATS:IGV) | +4.79% | 3.26 points |
| ServiceNow Inc. NYSE:NOW | +3.45% | 4.60 points |
| Appian Corp. NASDAQ:APPN | +2.78% | 5.27 points |
| Salesforce Inc. NYSE:CRM | +2.71% | 5.34 points |
| Pegasystems Inc. NASDAQ:PEGA | +1.18% | 6.87 points |
UiPath outperformed the sector ETF by 3.26 percentage points. The margin over its workflow software rivals was even greater.
There was little company-specific news available. UiPath’s investor page had not posted any new financial updates. The most recent news entry was from June 16, and the latest 8-K filing appeared on June 29.
Product notes from August 3-4 detailed updates to .NET 10, licensing management, and bug resolutions. No changes to financial guidance were included. Immediate market movement is probably being influenced by sector sentiment instead. This remains an observation, not a validated reason.
Recent financial results showed improvement. First-quarter revenue came in 5.3% above the midpoint of earlier guidance. Non-GAAP operating income surpassed its forecast by 15%.
| Q1 fiscal 2027 metric | Actual | Prior guidance midpoint | Difference |
|---|---|---|---|
| Revenue | $418.4 million | $397.5 million | +5.3% |
| ARR | $1.901 billion | $1.8965 billion | +0.2% |
| Non-GAAP operating income | $92 million | $80 million | +15.0% |
The company’s issued ranges are used to determine the guidance midpoints.
Revenue increased by 17% compared to the previous year. ARR climbed 12%, and net retention came in at 109%. The sum of cash and marketable securities stood at $1.42 billion.
Chief Executive Daniel Dines stated that agentic products were “moving from pilot to production.” Chief Financial Officer Ashim Gupta noted that GAAP profitability was achieved “for the first time in company history.” UiPath, Inc.
UiPath increased its full-year forecast following the quarter, with the updated midpoint indicating a 10.4% rise in revenue. Annualized recurring revenue is up 11.2%, and non-GAAP operating income is set to climb 16.2%.
| Fiscal-year metric | FY2026 actual | FY2027 midpoint | Implied change |
|---|---|---|---|
| Revenue | $1.611 billion | $1.7785 billion | +10.4% |
| Year-end ARR | $1.853 billion | $2.0605 billion | +11.2% |
| Non-GAAP operating income | $370 million | $430 million | +16.2% |
| Non-GAAP operating margin | 23.0% | 24.2% | +1.2 points |
FY2027 numbers reflect the midpoint values from UiPath’s latest guidance.
Profit is increasing at a quicker pace than sales, which is a positive sign. Still, UiPath’s market capitalization of $7.44 billion stands at 4.2 times the midpoint of its revenue outlook. Cash makes up about 19% of that overall valuation.
The immediate challenge is tougher. The forecast for the second quarter indicates a decline in both revenue and operating profit. It also suggests a significant decrease in net-new ARR for the quarter.
| Metric | Q1 actual | Q2 guidance midpoint | Sequential change |
|---|---|---|---|
| Revenue | $418.4 million | $397.5 million | -5.0% |
| Ending ARR | $1.901 billion | $1.9315 billion | +1.6% |
| Net-new ARR | $49 million | $30.5 million | -37.8% |
| Non-GAAP operating income | $92 million | $75 million | -18.5% |
The initial estimate is derived by deducting Q1 ending ARR from the midpoint of Q2.
Wall Street is staying careful, with 12 out of 15 analysts assigning a Hold rating to the stock. The consensus price target stands at $13.27, with the highest at $15. Based on Tuesday’s closing price, that reflects a potential decline of 5.9% to the average target.
Risks: The outlook for Q2 suggests lower sequential revenue and profit. Shortfalls in ARR, retention or margins could reverse recent gains. UiPath highlights customer retention, AI execution, and competition as significant risks.
UiPath has been recognized for improved execution. The company’s next phase requires tangible results rather than another sector rerating. Q2 ARR will be the key metric.
Related articles: NASDAQ:PLTR
